NSE: MPHASIS | BSE: 526299

Mid-range Performer

Download real time

2503.40 -35.20 (-1.39%)

52W Low on Apr 07, 2025

1.0M NSE+BSE Volume

NSE 28 Apr, 2025 3:31 PM (IST)

47,583.8

Market Cap

High in industry

1.2

Beta 1Year

Very High Volatility

Estimates Beat

MphasiS' Q4FY25 revenue of Rs 3,770 crore beats Forecaster estimates by 1.6% See details

MphasiS Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for MPHASIS, BSE:526299 MphasiS Ltd.

MphasiS Ltd.

22 Oct 2023

2503.40

-1.39%

Weakness easing but yet to gain momentum

Neutral: MphasiS Ltd.

Target

Motilal Oswal

MphasiS Ltd. has an average target of 2730.25 from 4 brokers.

MphasiS Ltd.

20 Oct 2023

2503.40

-1.39%

Multiple headwinds ahead; reiterate SELL

Sell: MphasiS Ltd.

Target

ICICI Securities Limited

Mphasis reported a big miss on revenue with flat QoQ CC growth (vs. ISEC: +1.8%) and 0.1% QoQ USD (vs. ISEC: +1.9%; consensus: +2.1%) led by challenges in conversion of TCV to revenue, discretionary spend cuts, and continued challenge in DR business as well as BFS ex-DR. Deal TCV was soft at USD 255mn, down 16% YoY, partly due to higher conversion of pipeline to TCV in Q1FY24.

Number of FII/FPI investors increased from 1002 to 1016 in Mar 2025 qtr.

MphasiS Ltd.

27 Aug 2023, 12:00AM

2503.40

-1.39%

Demand headwinds in BFS (largest vertical) persist, but the same is not reflected in valuations; reiterate SELL

Sell: MphasiS Ltd.

ICICI Securities Limited

We attended Mphasis analyst meet wherein the company outlined its future growth strategies: 1) focus on expanding non-BFS verticals, 2) continuing strategy of proactive large deal wins, and 3) increasing the number of clients with high revenue potential (USD 100mn+ annually).

MphasiS Ltd. is trading below its 100 day SMA of 2672.0

MphasiS Ltd.

27 Aug 2023, 12:00AM

2503.40

-1.39%

Growth to recover in FY25 | Valuation remains full

Neutral: MphasiS Ltd.

Recommendation Target

Motilal Oswal

Number of MF schemes increased from 213 to 221 in Mar 2025 qtr.

MphasiS Ltd.

25 Jul 2023

2503.40

-1.39%

Growth expected to come back in H2; margin resilient

Hold: MphasiS Ltd.

Recommendation Target

Bonanza

Mphasis reported a miss in revenue, which fell 3.5% QoQ in cc terms, -3.4% QoQ / -8.4% YoY. The revenue decline was due to weakness in banking and capital markets (BCM, -8.8% QoQ, -14.8% YoY). BCM ex-mortgage was down 8.7% QoQ given delayed decision-making across large banks and weakness in regional banks.

Number of MF schemes increased from 213 to 221 in Mar 2025 qtr.

MphasiS Ltd.

23 Jul 2023

2503.40

-1.39%

High mortgage and BFSI exposure leading to third consecutive decline in quarterly revenues; downgrade to SELL

Sell: MphasiS Ltd.

Recommendation Target

ICICI Securities Limited

Mphasis reported a miss in revenue, which fell -3.5% QoQ CC, -3.4% QoQ USD (I-Sec: -0.9%, cons: 0.01% USD) and -8.4% YoY CC. The revenue decline was due to weakness in banking and capital markets (BCM, -8.8% QoQ, -14.8% YoY). BCM ex-mortgage was down 8.7% QoQ given delayed decision-making across large banks and weakness in regional banks.

MphasiS Ltd. is trading above its 50 day SMA of 2401.4

MphasiS Ltd.

22 Jul 2023

2503.40

-1.39%

Mphasis (HOLD): Tepid Q1; cut to HOLD post runup

Hold: MphasiS Ltd.

Recommendation

BOB Capital Markets Ltd.

Q1 missed estimates as dollar revenue slipped 3.4% QoQ following a slowdown in both direct business and DXC

Number of MF schemes increased from 213 to 221 in Mar 2025 qtr.

MphasiS Ltd.

29 May 2023

2503.40

-1.39%

Mphasis (BUY): Dull quarter; sequential recovery guided from Q2

Buy: MphasiS Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Weak Q4 revenue print (-4.1% QoQ); DR and DXC remained a drag on growth

MphasiS Ltd. has an average target of 2730.25 from 4 brokers.

MphasiS Ltd.

02 May 2023

2503.40

-1.39%

Growth expected to come back in H2; margin resilient

Buy: MphasiS Ltd.

Target

Bonanza

Mphasis posted weak revenue print, yet maintained its margins. FY23 growth of 9.7% in cc terms was impacted by 4% from a decline in Digital Risk and 1.6% from a decline in DXC business. The increase in deal pipeline by 35% YoY including higher growth in non-BFSI deal pipeline is a sign of portfolio diversification and/or relative stress in BFSI (60% of revenue).